Literature DB >> 7718839

Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Côte d'Ivoire.

S B Richards1, M E St Louis, P Nieburg, I M Coulibaly, D Coulibaly, L Abouya, H D Gayle, K M De Cock.   

Abstract

SETTING: West African capital city with excellent, population-based notification of tuberculosis cases during a decade with a rapidly emerging HIV epidemic.
OBJECTIVE: To evaluate the impact of the HIV epidemic on tuberculosis in Abidjan, Côte d'Ivoire.
DESIGN: Review of data on all cases of tuberculosis registered in the city in alternate years from 1981 to 1991 and calculation of population-based rates using census data. Also, systematic study of HIV seroprevalence among tuberculosis patients in 1989 and 1991.
RESULTS: In 1981, several years before any health consequences of HIV were discernible in Abidjan, the incidence of tuberculosis was 155 per 100,000. By 1991, the rate of tuberculosis among HIV-seronegative persons had decreased by 38% to 96 per 100,000; however, 43.6% of tuberculosis patients were HIV-infected, and the incidence of tuberculosis among HIV-infected persons was 1104 per 100,000 (relative risk 11.5, 95% CI 10.8-12.3), yielding an overall observed incidence of tuberculosis of 159 per 100,000 population. The population attributable risk of tuberculosis due to HIV infection increased from 36% to 40% between 1989 and 1991.
CONCLUSIONS: The HIV epidemic has reversed the expected steep decline in tuberculosis in Abidjan over the past decade, and the impact of HIV infection on the incidence of tuberculosis may be accelerating.

Entities:  

Mesh:

Year:  1995        PMID: 7718839     DOI: 10.1016/0962-8479(95)90572-3

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  6 in total

1.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

2.  Tuberculosis control in resource-poor settings with high rates of HIV infection.

Authors:  K M De Cock
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

3.  Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis.

Authors:  R N Mshana; G Tadesse; G Abate; H Miörner
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.

Authors:  Bruce J Kirenga; Willy Ssengooba; Catherine Muwonge; Lydia Nakiyingi; Stephen Kyaligonza; Samuel Kasozi; Frank Mugabe; Martin Boeree; Moses Joloba; Alphonse Okwera
Journal:  BMC Public Health       Date:  2015-01-21       Impact factor: 3.295

5.  Low specificity of HIV-testing on sputum specimens kept at ambient temperatures for 4 to 7 days: a blinded comparison.

Authors:  Saidi M Egwaga; Timothy M Chonde; Mecky I Matee; Sayoki G Mfinanga; Prosper E Ngowi; Fred Lwilla; Frank G J Cobelens
Journal:  BMC Clin Pathol       Date:  2007-09-19

6.  Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012.

Authors:  Courtney M Yuen; Herman O Weyenga; Andrea A Kim; Timothy Malika; Hellen Muttai; Abraham Katana; Lucy Nganga; Kevin P Cain; Kevin M De Cock
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.